PROVAXS-Ghent University has concluded a partnership agreement with the Swedish veterinary diagnostic company, Boehringer Ingelheim Svanova for the commercial launch of a new ELISA kit. The ELISA was developed at the Laboratory of Parasitology of Professor Jozef Vercruysse at Ghent University.
The kit will help farmers and veterinarians to gain further insights into Fasciola hepatica and the parasite’s impact on production results. This new knowledge will ultimately ensure better parasite control and more efficient animal production.
The liver fluke Fasciola hepatica is a common parasite affecting animals as well as humans throughout the world. In cattle, fasciolosis is generally considered a subclinical disease but studies have shown that Fasciola hepatica infection can lead to progressive production losses in cattle farming.
“In infected animals we often see liver condemnations at slaughter but also issues such as lower weight gains, reduced milk production and reduced fertility which results in economic losses for the farmer” explains Dr. Johannes Charlier from Ghent University.
With the SVANOVIR®F.hepatica-Ab ELISA test kit, herds and individual animals that exceed an acceptable level of infection can be identified. The test results can support the implementation of control measures in the farm.
“Monitoring and controlling herd infection to an acceptable level with no loss of production is a new way to manage fasciolosis. The SVANOVIR®F.hepatica-Ab is a novel tool that provides hard facts for optimizing pasture management and treatment strategies which are the two most commonly used control measures” concludes Dr. Johannes Charlier from Ghent University.
The launch of the SVANOVIR®F.hepatica-Ab is another example of successful collaboration between university and the private sector for transferring applied research to market needs. Boehringer Ingelheim Svanova development team has 25 years of experience in commercialising immunoassays that are successfully controlling infectious diseases caused by viruses, bacteria and parasites in production animals. “We are able to bring unique diagnostic solutions to the market quickly by combining indebt knowledge about the development of robust diagnostic assays and a large distribution network” explains Niels From Head of Boehringer Ingelheim Svanova.
For more information on the ELISA please visit : www.svanova.com/products/bovine/bp19.html